We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

ICON plc (ICLR) Ordinary EUR0.06

Sell:$220.05 Buy:$220.59 Change: $0.30 (0.14%)
NASDAQ:0.20%
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$220.05
Buy:$220.59
Change: $0.30 (0.14%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$220.05
Buy:$220.59
Change: $0.30 (0.14%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

ICON Public Limited Company is a clinical research organisation (CRO). The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. The Company specialises in the strategic development, management and analysis of programs that support clinical development from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.

Contact details

Address:
South County Business Park, Dublin 18
DUBLIN
00000
Ireland
Telephone:
+353 (1) 2912000
Website:
www.iconplc.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ICLR
ISIN:
IE0005711209
Market cap:
$17.94 billion
Shares in issue:
81.29 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
Ireland
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Stephen Cutler
    Chief Executive Officer, Director
  • Brendan Brennan
    Chief Financial Officer
  • Diarmaid Cunningham
    Executive Vice President, Chief Administrative Officer, General Counsel, Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.